Translate
Ligand Pharmaceuticals Incorporated
About
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Apr 22 2026
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 14 2026
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
Mar 26 2026
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
Feb 26 2026
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
Financials
Revenue
$268.09 M
Market Cap
$3.98 B
P/E Ratio
32.51
EPS
6.14